跳至主要内容
临床试验/ISRCTN43866427
ISRCTN43866427已完成不适用

A randomised study of continuous infusional 5-fluorouracil (5FU) with or without bolus mitomycin-C in patients with advanced oesophago-gastric cancer

The Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 254 人开始时间: 2002年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
254

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Histological evidence of metastatic carcinoma of the oesophagus or stomach
  • 2. Histological evidence of locally advanced oesophageal or gastric carcinoma, not amenable to surgery or radiotherapy and for whom high dose chemotherapy or more intensive chemotherapy is not appropriate, normally around the age of 60

排除标准

  • 1. Intra-cerebral metastases
  • 2. History of other malignancy (apart from adequately treated non-melanotic skin cancer or carcinoma in situ of the uterine cervix)
  • 3. Uncontrolled angina pectoris or clinically significant cardiac dysrhythmias
  • 4. Pregnancy
  • 5. Any psychological condition precluding informed consent

研究者

发起方
The Royal Marsden NHS Foundation Trust (UK)

相似试验